Q1 Earnings Estimate for ImmunityBio Issued By HC Wainwright
ImmunityBio, Inc. (NASDAQ:IBRX – Free Report) – Analysts at HC Wainwright issued their Q1 2025 earnings estimates for ImmunityBio in a report issued on Thursday, March 6th. HC Wainwright analyst A. Maldonado expects that the company will post earnings of ($0.12) per share for the quarter. HC Wainwright has a “Buy” rating and a $8.00 […]
